DIETARY SUPPLEMENT CONTRACT MANUFACTURER AND FOOD SUPPLEMENT CDMO IN POLAND
GLOBAL CONTRACT MANUFACTURING FOR DIETARY SUPPLEMENTS, NUTRACEUTICALS, SPORTS NUTRITION, AND MEDICAL-GRADE FOOD SUPPLEMENTS — PHYSICIAN CHANNEL, PREMIUM BRAND, AND PE-FUND READY
Olympia Biosciences™ is a certified dietary supplement contract manufacturer and food supplement CDMO located in Poland, serving brand owners, physician-led practices, sports nutrition companies, influencer-led supplement brands, and nutraceutical innovators across the US, EU, and MENA. Our supplement manufacturing facility operates under ISO 22000, GMP, and FDA registration — delivering professional-grade supplement contract manufacturing from formulation through commercial-scale production with full IP ownership transferred to the client. We are not a private-label catalogue. Every dietary supplement contract manufacturing programme begins with a paid scientific due-diligence gate that confirms formulation feasibility, regulatory fit, and market readiness before capital is committed.
STRUCTURAL ASYMMETRY · MANIFESTO §3
0 own consumer brands. 0 competing SKUs. 0 channel conflict.
OWN CONSUMER BRANDS
0
COMPETING SKUS HELD
0
EXCLUSIVITY CLAUSES VIOLATED
0
VERIFIED QUALITY, COMPLIANCE, AND EXECUTION EVIDENCE
Olympia operates as a zero-conflict CDMO with no internal consumer brands. The Legal Hub publishes the current status and scope of quality, registration and information-security records. Programme-specific quality, technical and regulatory boundaries are confirmed through the agreed scope.
FOOD SAFETY MANAGEMENT CERTIFIED
CONSUMER BRANDS OWNED
CONTROLS DEFINED PER PROJECT
SECURITY AND NDA BOUNDARY
For qualified brands, this means contract development and manufacturing under a zero-conflict model: no catalogue formulas, no competing in-house SKUs, and no dilution of active-substance logic to fit a generic private-label template.
TRUST IS CHEAP. PUBLIC RECORDS ARE NOT.
Due-diligence evidence must be checked from the relevant published source rather than inferred from marketing language. The Legal Hub and approved confidential diligence route identify the public and project-specific evidence boundaries available before a commercial commitment.
Premium dietary-supplement and medical-nutrition programmes should be evaluated on evidence, governance and technical fit. Public media coverage is not a substitute for project-specific diligence and contractual scope.
Founder statement: In an industry dominated by marketing noise and ready-made catalogue formulas, we build market wins backed by hard evidence.
OLIMPIA BARANOWSKA · CEO & SCIENTIFIC DIRECTOR
MOST-READ CLINICAL INTELLIGENCE — LIVE RANKING
Enteric-Targeted Butyrate Delivery for Vagal Nerve Stimulation: Addressing Gastric Degradation and Organoleptic Challenges
Our gut produces a helpful chemical called butyrate, which is important for gut health and how our gut talks to our…
Major Advances in Rheumatology: 2025–2026 Breakthroughs
Treatments for chronic conditions where the body's own defense system mistakenly attacks itself, like lupus and art…
Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC
Doctors are developing highly personalized vaccines to help fight cancer. These vaccines are custom-made for each p…
MOST-READ COMMERCIALIZATION INTELLIGENCE — LIVE RANKING
The decisions that determine whether a product launch holds.
Market-entry, regulatory and CDMO due-diligence guidance for clinician-led and premium nutrition brands.
Launching Clinician-Branded Dietary Supplements and Medical Nutrition Products Across Priority Markets
Commercializing clinician-branded products involves significant risk if incorrectly classified, as market regulations differentiate …
Global Medical Food and FSMP Market Entry: Navigating Regulatory Pathways and Commercial Strategy
Companies face significant commercial and regulatory risk if a nutritional product is misclassified as a medical food or Food for Sp…
Supplement Manufacturing Timeline: The Critical Path from Product Brief to First Commercial Batch
Committing to supplement launch timelines or product specifications without first defining critical product, market, and regulatory …
Advanced CDMO Organisation: Olympia Biosciences™ and IOC Sp. z o.o.
Olympia Biosciences™ is the international brand and strategic technology division of IOC Sp. z o.o., a company operating continuously since 2009 on the basis of 100% Polish capital. Headquartered in Gdynia, Poland, we provide comprehensive B2B infrastructure for global premium brands and the medical sector. The primary pillar of our operations is large-scale contract manufacturing of dietary supplements, functional foods, and Foods for Special Medical Purposes (FSMP).
Two Dedicated Manufacturing Facilities and Certification (2025–2029)
Supply chain security is built on two independent production facilities in Poland. Facility I is dedicated to the manufacturing of medically significant cosmetics (GMP ISO 22716), while Facility II handles the production of dietary supplements and food products (GMP, HACCP, ISO 22000:2018). The entire process is overseen by Olimpia Baranowska, who combines expertise in technical physics with formulation engineering — enabling the development of advanced softgel capsules and micellar delivery systems.
Our machinery and quality management systems have been validated by the independent notified body POLCARGO GROUP Ltd. (certification valid until 21 February 2029). We maintain full compliance with the guidelines of the Chief Sanitary Inspectorate (GIS), EFSA standards, Codex Alimentarius, and hold an active registration with the U.S. Food and Drug Administration (FDA Reg. No. 12507446544).
Zero-Conflict Policy and Intellectual Property Protection
We operate under a strict pure-play B2B model. Partners receive full transfer of intellectual property (IP) rights to developed formulas. As a certified contract supplement manufacturer, we develop no internal consumer brands — guaranteeing zero conflict of interest. Information security, including NDA agreements and targeted formulas, is protected under the rigorous ISO/IEC 27001:2023 standard.
Market Trust, Stock Exchange Validation, and R&D Awards
The operational capabilities of IOC Sp. z o.o. are continuously verified by capital markets and scientific institutions, establishing a transparent environment for technical due diligence.
- 01
WSE Exchange Reports: We serve as the official Contract Manufacturing Organization (CMO) for clinical-grade micellar technologies, as documented in official reports of companies listed on the Warsaw Stock Exchange.
- 02
Scientific Recognition (2025): We were awarded the Rome-issued "International Leader in Scientific Excellence" distinction in the field of dietary supplement manufacturing.
- 03
Government Patronage: We are a recipient of the Best in Business Award 2025, granted under the honorary patronage of the National Centre for Research and Development (NCBiR).
- 04
Business Scaling: The European Business Institute regularly recognizes us with the title "Business Gepard" for exceptional operational growth dynamics (+1966%), confirming our capacity to support multi-million-dollar contracts.
PAID DISCOVERY — SCIENTIFIC CONTROL GATE FOR DIETARY SUPPLEMENT CONTRACT MANUFACTURING
Most dietary supplement manufacturers in Poland and globally accept any project brief and begin production without rigorous feasibility validation. The result is formulas that fail stability testing, exceed regulatory tolerance thresholds, or reach market with insufficient evidence to support the intended positioning. Olympia Biosciences™ operates differently. Every contract manufacturing dietary supplement programme — regardless of budget or brand size — begins with a structured Paid Discovery process.
Paid Discovery is a paid, time-bounded scientific control gate. It confirms: formulation feasibility and physical-chemistry constraints; the evidence boundary required to support the intended product claims; the regulatory pathway for each target market (EU notification, FDA registration, MENA frameworks); and the technical and commercial scope of the full manufacturing programme. Programmes that pass Paid Discovery proceed to a detailed scoped Work Order. Programmes that do not pass are declined — regardless of commercial pressure. This is how Olympia maintains its 17-year record of zero quality complaints.
EVIDENCE-BASED RESEARCH SERVICES
Methodological support for literature reviews and evidence-based scientific assessments.
Beyond formulation architecture, Olympia supports structured research services for locked product briefs: review-question framing, literature-screening logic, endpoint mapping, study hierarchy, and dossier-ready evidence summaries used in decision-grade scientific assessments.
WHAT PAID DISCOVERY CONFIRMS
- > ELIMINATES NON-TECHNICAL BRIEFS AND PRICE-ONLY REQUESTS.
- > CONFIRMS SCIENTIFIC SCOPE, REGULATORY PATH, AND EXECUTION CAPACITY ACROSS US, EU, AND MENA MARKETS.
- > DEFINES THE RIGHT MANUFACTURING SPECIFICATION BEFORE SCALE-UP CAPITAL IS COMMITTED.
- > DELAYED FORMULATION START MEANS HIGHER PROGRAMME COST AND NARROWING REGULATORY WINDOWS.
Frequently Asked Questions
Key definitions and operational policies regarding contract manufacturing, IP ownership, and our zero-conflict structure.
Frequently Asked Questions
What is dietary supplement contract manufacturing and how does it differ from private-label?
Why choose a Polish dietary supplement manufacturer over factories in Asia or Western Europe?
What certifications does Olympia Biosciences™ hold as a food supplement contract manufacturer?
Does Olympia Biosciences™ work as a supplement co-packer or contract packaging company?
Can Olympia Biosciences™ manufacture sports nutrition supplements and nutraceuticals?
What makes Olympia Biosciences™ a professional-grade supplement manufacturer?
How does Olympia Biosciences™ support FSMP and medical-food manufacturing?
WE QUALIFY FOR SCIENTIFIC FIT BEFORE COMMERCIAL SCALE
From premium physician-led supplements to FSMP, medical food, and clinical nutrition, Olympia builds the right scientific, regulatory, and execution path for each programme. Projects requiring clinical-development support are individually scoped, not forced into a generic quotation. Supplement and premium brand projects enter through Paid Discovery. FSMP and medical nutrition projects follow bespoke FSMP scoping.
INITIATE R&D DUE DILIGENCEEXPLORE OLYMPIA BIOSCIENCES™